Prosecution Insights
Last updated: April 19, 2026

Enlitisa (Shanghai) Pharmaceutical Co. Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18612989 PHARMACEUTICAL USE REYNOLDS, FRED H 1658 Final Rejection Mar 21, 2024
17781571 PEPTIDES AND THEIR USE IN THE TREATMENT OF INFLAMMATION STEELE, AMBER D 1658 Non-Final OA Jun 09, 2022
17781438 NEW MULTI-FUNCTIONAL OLIGOPEPTIDES COFFA, SERGIO 1658 Non-Final OA Jun 01, 2022
17781543 NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE COFFA, SERGIO 1658 Non-Final OA Jun 01, 2022

Managing Enlitisa (Shanghai) Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month